Gene expression profiling of multiple myeloma plasma cells allows identification of potential molecular determinants of lytic bone disease.

被引：0
|
作者：
Zhan, FH
Randolph, C
Suva, L
Barlogie, B
Epstein, J
Shaughnessy, J
机构：
[1] Univ Arkansas Med Sci, Dept Orthopaed, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
782
引用
收藏
页码：208A / 208A
页数：1
相关论文
共 50 条
  • [31] Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling
    Shaughnessy, JD
    Barlogie, B
    IMMUNOLOGICAL REVIEWS, 2003, 194 (01) : 140 - 163
  • [32] Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing
    Agnelli, Luca
    Tassone, Pierfrancesco
    Neri, Antonino
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 : S55 - S68
  • [33] CD166 Identifies Multiple Myeloma Cells That Preferentially Home to the Bone Marrow Microenvironment and Promote Disease Progression and Bone Lytic Disease
    Xu, Linlin
    Machal, Christophe
    Wu, Hao
    Crean, Colin D.
    Poteat, Bradley
    Cardoso, Angelo A.
    Hanenberg, Helmut
    Mohammad, Khalid
    Suvannasankha, Attaya
    Srour, Edward F.
    BLOOD, 2014, 124 (21)
  • [34] Identification of the key genes connected with plasma cells of multiple myeloma using expression profiles
    Zhang, Kefeng
    Xu, Zhongyang
    Sun, Zhaoyun
    ONCOTARGETS AND THERAPY, 2015, 8 : 1795 - 1803
  • [35] Gene expression profiling of plasma cell dyscrasias: The role of IGH translocations in the heterogeneity of multiple myeloma.
    Neri, A
    Mattioli, M
    Agnelli, L
    Fabris, S
    Baldini, L
    Morabito, F
    Bicciato, S
    Verdelli, D
    Intini, D
    Nobili, L
    Cro, L
    Pruneri, G
    Callea, V
    Stelitano, C
    Lombardi, L
    BLOOD, 2004, 104 (11) : 294B - 294B
  • [36] CD45 EXPRESSION BY BONE MARROW PLASMA CELLS AT DIAGNOSIS IN MULTIPLE MYELOMA: CORRELATION WITH MINIMAL RESIDUAL DISEASE
    Safra, I.
    Lakhal, A.
    Ladeb, S.
    Torjemane, L.
    Ben Jemaa, R.
    Ben Abdeladhim, A.
    Ben Othman, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 572 - 573
  • [37] THE ROLE OF EXPRESSION CD56 ON BONE MARROW PLASMA CELLS AND EXTRAMEDULLARY PLASMA CELLS IN PATIENTS WITH MULTIPLE MYELOMA
    Firsova, M.
    Mendeleeva, L.
    Kovrigina, A.
    Soloviev, M.
    Pokrovskaya, O.
    Nareyko, M.
    Kuzmina, L.
    Savchenko, V.
    HAEMATOLOGICA, 2017, 102 : 795 - 796
  • [38] Gene expression profiling in multiple myeloma cells treated with the novel anti-myeloma agents zoledronate and fluvastatin.
    Molloy, TJ
    Cindy, BB
    Deng, YM
    Spencer, A
    Ma, DF
    BLOOD, 2005, 106 (11) : 351B - 351B
  • [39] Gene expression profiling analysis identifies novel potential cancer-testis antigens in multiple myeloma
    Condomines, M.
    Hose, D.
    Reme, T.
    De Vos, J.
    Pantesco, V.
    Requirand, G.
    Schved, J. F.
    Rossi, J. F.
    Goldschmidt, H.
    Klein, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 97 - 98
  • [40] Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
    Tobias Meißner
    Anja Seckinger
    Kari Hemminki
    Uta Bertsch
    Asta Foersti
    Mathias Haenel
    Jan Duering
    Hans Salwender
    Hartmut Goldschmidt
    Gareth J. Morgan
    Dirk Hose
    Niels Weinhold
    BMC Medical Genomics, 8
12345